Crinetics Pharmaceuticals CRNX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Crinetics Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's operating margin?
- Crinetics Pharmaceuticals (CRNX) reported operating margin of -3,020.3% in Q1 2026.
- How has Crinetics Pharmaceuticals's operating margin changed year-over-year?
- Crinetics Pharmaceuticals's operating margin increased by 93.9% year-over-year, from -49,569.7% to -3,020.3%.
- What is the long-term trend for Crinetics Pharmaceuticals's operating margin?
- Over 4 years (2021 to 2025), Crinetics Pharmaceuticals's operating margin has grown at a -9.5% compound annual growth rate (CAGR), from -9,990.9% to -6,714.8%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.